- Home
- TRMB vs ICLR Comparison
TRMB vs ICLR Comparison
Compare TRMB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMB
- ICLR
- Stock Information
- Founded
- TRMB 1978
- ICLR 1990
- Country
- TRMB United States
- ICLR Ireland
- Employees
- TRMB N/A
- ICLR N/A
- Industry
- TRMB Industrial Machinery/Components
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TRMB Industrials
- ICLR Health Care
- Exchange
- TRMB Nasdaq
- ICLR Nasdaq
- Market Cap
- TRMB 17.7B
- ICLR 17.2B
- IPO Year
- TRMB 1990
- ICLR 1998
- Fundamental
- Price
- TRMB $74.92
- ICLR $198.11
- Analyst Decision
- TRMB Buy
- ICLR Strong Buy
- Analyst Count
- TRMB 7
- ICLR 12
- Target Price
- TRMB $82.29
- ICLR $284.82
- AVG Volume (30 Days)
- TRMB 1.2M
- ICLR 903.2K
- Earning Date
- TRMB 02-10-2025
- ICLR 02-19-2025
- Dividend Yield
- TRMB N/A
- ICLR N/A
- EPS Growth
- TRMB 342.93
- ICLR 44.49
- EPS
- TRMB 5.97
- ICLR 8.99
- Revenue
- TRMB $3,632,300,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- TRMB N/A
- ICLR $3.95
- Revenue Next Year
- TRMB N/A
- ICLR $2.84
- P/E Ratio
- TRMB $12.55
- ICLR $22.04
- Revenue Growth
- TRMB N/A
- ICLR 3.63
- 52 Week Low
- TRMB $48.65
- ICLR $183.38
- 52 Week High
- TRMB $76.97
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- TRMB 63.33
- ICLR 35.86
- Support Level
- TRMB $68.49
- ICLR $196.50
- Resistance Level
- TRMB $73.16
- ICLR $228.29
- Average True Range (ATR)
- TRMB 1.56
- ICLR 6.57
- MACD
- TRMB 0.30
- ICLR -1.36
- Stochastic Oscillator
- TRMB 96.84
- ICLR 5.06
About TRMB Trimble Inc.
Trimble Inc provides a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has four reportable segments: Buildings and Infrastructure, Geospatial, Resources and Utilities, and Transportation. The company generates the majority of its revenue from the Buildings and Infrastructure segment, which primarily serves customers working in architecture, engineering, construction, design, asset management, operations, and maintenance.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.